Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
M&A / Property Neutral

Mandeville Ventures Provides Update on Proposed Qualifying Transaction with Quantropi Inc.

Mandeville Extends Quantum Deal Timeline as Quantropi’s Heavy Liabilities and Funding Hurd Loom

By The Northwire Desk — AI Analysis Mar 31, 2026 · 17:00 MAND · 0.09
Executive Summary
  • The most recent release (March 31, 2026) announces an extension of the due diligence and definitive agreement negotiation period for the proposed Qualifying Transaction (QT) with Quantropi Inc. from March 30, 2026, to April 17, 2026.
  • The outside completion date for the transaction has been pushed back from June 30, 2026, to July 31, 2026.
  • Mandeville shares remain halted on the TSX Venture Exchange pending regulatory review and transaction completion.
  • This follows the December 29, 2025, Letter Agreement which outlined a three-cornered amalgamation contingent on Quantropi raising a minimum of US$2 million via private placement and Mandeville executing a share consolidation targeting a US$2.8 million aggregate post-closing value.
  • Historical context shows Mandeville held approximately CAD $1.3 million in cash as of August 31, 2025, with minimal operating expenses, while Quantropi reported FY2024 liabilities of $10.35 million against assets of $1.78 million and a net loss of $4.12 million.
Material Impact
  • The extension is administrative and does not alter the fundamental economics, structure, or contingent conditions of the proposed deal.
  • No new capital, revised valuation, or updated commercial milestones were disclosed.
  • The delay is consistent with standard CPC transaction timelines but signals ongoing negotiation complexity, regulatory pacing, or potential friction in finalizing definitive terms.
  • From a risk-averse perspective, the lack of progress toward a definitive agreement or successful private placement maintains the status quo of high uncertainty and capital lock-up for shareholders.
MAND · Price
Company Overview
  • Mandeville Ventures is a Capital Pool Company listed on the TSX Venture Exchange, designed to identify and merge with a private operating business.
  • The flagship initiative is the proposed QT with Quantropi Inc., a developer of quantum-secure cryptographic solutions intended to protect data against future quantum computing threats.
  • Upon successful completion, the combined entity will operate as Quantropi Corp., list as a Tier 2 technology issuer, and be led by a board featuring James Nguyen (CEO), Dr. Randy Kuang (Chief Scientist), and Marco Pagani (Chairman).
  • The technology remains in early commercialization stages with no disclosed recurring revenue streams in the provided data.
Read the original news release →

More from

Apr 24, 2026 · 16:59

Mandeville Ventures Finalizes Definitive Agreement for Quantropi Merger Amidst Financing Gaps and Balance Sheet Concerns

M&A / Property Apr 17, 2026 · 17:00

Mandeville Ventures Stalls Again: Quantropi Deal Delays Mount Amidst Halted Trading

M&A / Property Dec 29, 2025 · 17:22

Mandeville Ventures Announces Entry into Letter Agreement for Qualifying Transaction with Quantropi, Inc.

M&A / Property